Related Experiment Video
Updated: Nov 28, 2025

07:29
Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure
Published on: August 14, 2017
15.1K
Monosegment ALPPS for bilateral colorectal liver metastasis - One is enough
Klaus Steinbrück1,2, Reinaldo Fernandes1,2, Gustavo Stoduto2
1Equipe Multidisciplinar Hepatobiliar - EMHep.
Annals of Hepato-Biliary-Pancreatic Surgery
|November 25, 2020
Summary
Associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) can be a feasible monosegment procedure for extensive liver resections. This case highlights successful segment 4-1 ALPPS for bilobar colorectal liver metastasis.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastroenterology
Background:
- Extensive liver resections for extensive liver metastases require strategies to ensure adequate future liver remnant.
- Associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) is an option for patients with insufficient liver remnant.
- Monosegment ALPPS, leaving only one liver segment as remnant, is a modification of the original ALPPS procedure.
Observation:
- A 63-year-old man with bilobar colorectal liver metastasis underwent segment 4-1 ALPPS.
- The procedure involved two stages with a 21-day interval.
- The future liver remnant volume increased from 250 cc (18% of standard liver volume) to 694 cc (48% of standard liver volume).
Findings:
- Segment 4-1 ALPPS was successfully performed in a patient with extensive bilobar colorectal liver metastasis.
- The patient tolerated the procedure well, with a significant increase in liver remnant volume.
- The patient was disease-free ten months after liver surgery and subsequently underwent colectomy.
Implications:
- Monosegment ALPPS is a challenging but feasible option for selected patients requiring extensive liver resection.
- Careful patient selection and experienced surgical teams are crucial for successful outcomes in monosegment ALPPS.
- This approach can enable curative treatment for patients with extensive liver metastases previously considered unresectable.

